It triggers a clean, targeted pulse of growth hormone release with a favourable selectivity profile, meaning it is studied for stimulating GH release without strongly affecting other hormones such as cortisol or prolactin
Doyle and his research partners at the University of Pennsylvania and the University of Kentucky identified a chemical created by brain cells called astrocytes that could be key in designing future appetite control drugs without negative side effects
I also had wrist instability
#ClinicalTrials #DrugDevelopment #Diabetes #GLP #Weightloss To view or add a comment, sign in Treatment-Resistant Hypertension market is projected to grow at a CAGR of 6.30% by 2034, Companies: Idorsia, Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma, KBP: Treatment-Resistant Hypertension market Treatment-Resistant Hypertension market size in the 7MM was valued at approximately USD 6,958 million in 2025